cord blood-derived expanded natural killer cells PNK-007
Term · Oncology and biomedicine · MLC-T-ONC-012774
A population of allogeneic lytic natural killer (NK) cells derived from human umbilical cord blood (UCB), with potential cytotoxic activity. Hematopoietic stem cells (HSC) are isolated from human UCB; this is followed by ex vivo differentiation into mature, highly lytic, NK cells, and expansion. Upon administration, the CB-derived expanded NK cells PNK-007 may lyse cancer cells.
| Identifier | MLC-T-ONC-012774 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cord blood-derived expanded NK cells PNK-007; human CB-derived natural killer cells PNK-007 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012774",
"term": "cord blood-derived expanded natural killer cells PNK-007",
"field": "Oncology and biomedicine",
"definition": "A population of allogeneic lytic natural killer (NK) cells derived from human umbilical cord blood (UCB), with potential cytotoxic activity. Hematopoietic stem cells (HSC) are isolated from human UCB; this is followed by ex vivo differentiation into mature, highly lytic, NK cells, and expansion. Upon administration, the CB-derived expanded NK cells PNK-007 may lyse cancer cells.",
"synonyms": [
"cord blood-derived expanded NK cells PNK-007",
"human CB-derived natural killer cells PNK-007"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cord-blood-derived-expanded-natural-killer-cells-pnk-007/"
}
Record 5,327 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.